Golden State Medical Supply recalls niacin extended-release tablets because they failed a dissolution test
During stability testing at 12 months, one lot of these 1,000 mg tablets did not dissolve as required at the 24-hour mark, meaning the medicine may not release as intended.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.
- Hazard
- Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
- Units
- 2,961 bottles
- Where sold
- Within the U.S Market.
- FDA classification
- Class II · Ongoing
- Classified by FDA
- June 11, 2026
- Recall started
- May 29, 2026
- FDA enforcement report
- June 17, 2026
- Identifiers
- Codes: Lots: GS065128, GS065844, GS066695, GS067432, GS067993, expires: 01/31/2027.
- FDA recall number: D-0587-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.
- Reason for recall
- Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
- Classification
- Class II (Ongoing)
- Distribution
- Within the U.S Market.
- Quantity
- 2,961 bottles
Related recalls
Golden State Medical Supply recalls Prasugrel 10mg tablets because they failed dissolution testing
The manufacturer reported that a lot of these tablets failed dissolution testing, meaning the tablets may not dissolve as they should.
Golden State Medical Supply Inc. · 6791 30-count bottles
Golden State Medical Supply recalls primidone tablets over contamination with another drug's ingredient
The active ingredient in these primidone tablets, a prescription medicine, was contaminated with trace amounts of the ingredient acemetacin from another product.
Golden State Medical Supply Inc. · 10,146 units
Lannett recalls Niacin Extended-release Tablets 1,000 mg over failed dissolution test
During stability testing, the tablets failed a dissolution test at the 24-hour timepoint, with results coming in too low, so they did not meet the required release specifications.
Lannett Company Inc. · 3984 bottles
Lannett recalls Niacin Extended-release Tablets, USP, 1,000 mg because they failed dissolution specifications
The recalled 90-count bottles of Niacin Extended-release Tablets, USP, 1,000 mg failed dissolution specifications, and the notice does not say what this could do to a person.
Lannett Company Inc. · 46,848 90-count bottles